Reductions in AFP and PIVKA-II Can Predict the Efficiency of Anti-PD-1 Immunotherapy in HCC Patients

By
Justin.choi
-
0
7
The authors investigated the prognostic role of AFP and PIVKA-II in hepatocellular carcinoma patients receiving anti-PD-1 immunotherapy.
[BMC Cancer]

Sorry, but the selected Zotpress account can't be found.

Full Article